Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

87

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Tags:

Previous Article

Human Schwann cell lipid dysregulation and plasma membrane perturbation in Charc...

FerroTerminator1 as a potent therapeutic drug for MASH

Related Posts

Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma

Repurposing statins and phenothiazines to treat chemore...

37

Glial plasticity in the zebrafish central nervous system

Glial plasticity in the zebrafish central nervous system

88

Spatial biology – unravelling complexity within the glioblastoma microenvironment

Spatial biology – unravelling complexity within the gli...

109